These days, there is only one question on everyone's tongue, when will the vaccine be finally eliminated? When will the medicine arrive? So there is a great news for the countrymen among the answers to this question. Preparations have started for its production in India amid the trials regarding the vaccine. Indeed, the Pune-based Serum Institute of India (SII) lab is preparing to produce and supply the corona virus vaccine.British-Swedish pharma company AstraZeneca has announced that it has joined hands with India to supply the vaccine AZD1222 and is in a licensing agreement with SII. Oxford University has given the responsibility of supplying Corona its potential vaccine to the company AstraZeneca.

AstraZeneca and SII together are preparing to make a billion or 100 crore vaccine. Of this, 400 million vaccines are targeted to be supplied by the end of this year. The Corona virus vaccine produced in Pune will be supplied to low-income countries including India. Let us know that Oxford University is at the forefront of the race to make the Corona vaccine.
Let us know that Oxford University is at the forefront of the race to make the Corona vaccine. Here the vaccine trial has reached the second stage

Leading the Oxford Vaccine Trial
In the last 50 years, SII has played a major role in the production and supply of vaccines globally. SII is currently working on vaccine candidates developed by UK's Oxford, America's CodeGenics and Australia's biotech farm Themis. But Poonawala has the highest expectations from the Oxford University vaccine as it leads the trial. In addition, SII is also developing its own vaccine.